case_images: PMC10614021_01
case_images: Patient 1 treatment timeline. Allo-HSCT, allogeneic hematopoietic stem cell transplantation; CS, corticosteroids; MTX, methotrexate; NSAIDS, Non-steroidal anti-inflammatory drugs.
case_images: fmed-10-1275927-g001.jpg
case_images: PMC10614021_01_fmed-10-1275927-g001.jpg
case_images: fig1
case_images: The decision to proceed to allo-HSCT was based on ongoing disease activity refractory to eight lines of therapy as well as severe disease/treatment-related complications (Table 1 and Figure 1).
case_images: Patient 2 treatment timeline. Allo-HSCT, allogeneic hematopoietic stem cell transplantation; CS, corticosteroids; MTX, methotrexate; NSAIDS, Non-steroidal anti-inflammatory drugs.
case_images: fmed-10-1275927-g002.jpg
case_images: PMC10614021_01_fmed-10-1275927-g002.jpg
case_images: fig2
case_images: He was on moderate/high doses of CS since his diagnosis (3.8 years) (Figure 2).